AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Stroke genomics: Approaches to identify, validate, and understand ischemicstroke gene expression
Authors: Read, SJ Parsons, AA Harrison, DC Philpott, K Kabnick, K O'Brien, S Clark, S Brawner, M Bates, S Gloger, I Legos, JJ Barone, FC
Citation: Sj. Read et al., Stroke genomics: Approaches to identify, validate, and understand ischemicstroke gene expression, J CEREBR B, 21(7), 2001, pp. 755-778
p38 Activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis
Authors: McLaughlin, B Pal, S Tran, MP Parsons, AA Barone, FC Erhardt, JA Aizenman, E
Citation: B. Mclaughlin et al., p38 Activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis, J NEUROSC, 21(10), 2001, pp. 3303-3311
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia
Authors: Barone, FC Irving, EA Ray, AM Lee, JC Kassis, S Kumar, S Badger, AM Legos, JJ Erhardt, JA Ohlstein, EH Hunter, AJ Harrison, DC Philpott, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia, MED RES REV, 21(2), 2001, pp. 129-145
Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation
Authors: Bates, S Read, SJ Harrison, DC Topp, S Morrow, R Gale, D Murdock, P Barone, FC Parsons, AA Gloger, IS
Citation: S. Bates et al., Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation, MOL BRAIN R, 93(1), 2001, pp. 70-80
Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction
Authors: Willette, RN Anderson, KM Nelson, AH Olzinski, AR Woods, T Coatney, RW Aiyar, N Ohlstein, EH Barone, FC
Citation: Rn. Willette et al., Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction, J CARDIO PH, 38(4), 2001, pp. 606-617
Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban
Authors: Erhardt, JA Ohlstein, EH Toomey, JR Gabriel, MA Willette, RN Yue, TL Barone, FC Parsons, AA
Citation: Ja. Erhardt et al., Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban, THROMB RES, 103(2), 2001, pp. 143-148
Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats
Authors: Ma, XL Gao, F Nelson, AH Lopez, BL Christopher, TA Yue, TL Barone, FC
Citation: Xl. Ma et al., Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats, J PHARM EXP, 298(3), 2001, pp. 879-885
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia
Authors: Barone, FC Irving, EA May, AM Lee, JC Kassis, S Kumar, S Badger, AM White, RF McVey, MJ Legos, JJ Erhardt, JA Nelson, AH Ohlstein, EH Hunter, AJ Ward, K Smith, BR Adams, JL Parsons, AA
Citation: Fc. Barone et al., SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia, J PHARM EXP, 296(2), 2001, pp. 312-321
Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS)
Authors: Vonhof, S Barone, FC Price, WJ Paakkari, P Millison, JH Feuerstein, GZ Siren, ALK
Citation: S. Vonhof et al., Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS), EUR J PHARM, 416(1-2), 2001, pp. 83-93
Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats
Authors: Barone, FC Coatney, RW Chandra, S Sarkar, SK Nelson, AH Contino, LC Brooks, DP Campbell, WG Ohlstein, EH Willette, RN
Citation: Fc. Barone et al., Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats, CARDIO RES, 50(3), 2001, pp. 525-537
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia
Authors: Legos, JJ Erhardt, JA White, RF Lenhard, SC Chandra, S Parsons, AA Tuma, RF Barone, FC
Citation: Jj. Legos et al., SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia, BRAIN RES, 892(1), 2001, pp. 70-77
Therapeutic potential of anti-inflammatory drugs in focal stroke
Authors: Barone, FC Parsons, AA
Citation: Fc. Barone et Aa. Parsons, Therapeutic potential of anti-inflammatory drugs in focal stroke, EXPERT OP I, 9(10), 2000, pp. 2281-2306
Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1 beta mRNA in ischemic brain tolerance
Authors: Wang, XK Li, X Currie, RW Willette, RN Barone, FC Feuerstein, GZ
Citation: Xk. Wang et al., Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1 beta mRNA in ischemic brain tolerance, J NEUROSC R, 59(2), 2000, pp. 238-246
Quantitative changes in interleukin proteins following focal stroke in therat
Authors: Legos, JJ Whitmore, RG Erhardt, JA Parsons, AA Tuma, RF Barone, FC
Citation: Jj. Legos et al., Quantitative changes in interleukin proteins following focal stroke in therat, NEUROSCI L, 282(3), 2000, pp. 189-192
The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke
Authors: Savitz, SI Erhardt, JA Anthony, JV Gupta, G Li, X Barone, FC Rosenbaum, DM
Citation: Si. Savitz et al., The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke, J CEREBR B, 20(8), 2000, pp. 1197-1204
Detection of tumor necrosis factor-alpha mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction
Authors: Wang, XK Li, X Erhardt, JA Barone, FC Feuerstein, GZ
Citation: Xk. Wang et al., Detection of tumor necrosis factor-alpha mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction, J CEREBR B, 20(1), 2000, pp. 15-20
Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat
Authors: Irving, EA Barone, FC Reith, AD Hadingham, SJ Parsons, AA
Citation: Ea. Irving et al., Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat, MOL BRAIN R, 77(1), 2000, pp. 65-75
Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat
Authors: Barone, FC Ohlstein, EH Hunter, AJ Campbell, CA Hadingham, SH Parsons, AA Yang, Y Shohami, E
Citation: Fc. Barone et al., Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat, J CARDIO PH, 36, 2000, pp. S357-S361
Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke
Authors: Wang, XK Li, X Schmidt, DB Foley, JJ Barone, FC Ames, RS Sarau, HM
Citation: Xk. Wang et al., Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke, MOLEC PHARM, 57(6), 2000, pp. 1190-1198
Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist
Authors: Sarau, HM Griswold, DE Bush, B Potts, W Sandhu, P Lundberg, D Foley, JJ Schmidt, DB Webb, EF Martin, LD Legos, JJ Whitmore, RG Barone, FC Medhurst, AD Luttmann, MA Giardina, GAM Hay, DWP
Citation: Hm. Sarau et al., Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist, J PHARM EXP, 295(1), 2000, pp. 373-381
Characterisation of SB-221420-A - a neuronal Ca2+ and Na+ channel antagonist in experimental models of stroke
Authors: Campbell, CA Barone, FC Benham, CD Hadingham, SJ Harries, MH Harling, JD Hills, JM Lewis, VA Mackay, KB Orlek, BS White, RF Parsons, AA Hunter, AJ
Citation: Ca. Campbell et al., Characterisation of SB-221420-A - a neuronal Ca2+ and Na+ channel antagonist in experimental models of stroke, EUR J PHARM, 401(3), 2000, pp. 419-428
Benign focal ischemic preconditioning induces neuronal Hsp70 and prolongedastrogliosis with expression of Hsp27
Authors: Currie, RW Ellison, JA White, RF Feuerstein, GZ Wang, XK Barone, FC
Citation: Rw. Currie et al., Benign focal ischemic preconditioning induces neuronal Hsp70 and prolongedastrogliosis with expression of Hsp27, BRAIN RES, 863(1-2), 2000, pp. 169-181
Inflammatory mediators and stroke: New opportunities for novel therapeutics
Authors: Barone, FC Feuerstein, GZ
Citation: Fc. Barone et Gz. Feuerstein, Inflammatory mediators and stroke: New opportunities for novel therapeutics, J CEREBR B, 19(8), 1999, pp. 819-834
Caspase-8 and caspase-3 are expressed by different populations of corticalneurons undergoing delayed cell death after focal stroke in the rat
Authors: Velier, JJ Ellison, JA Kikly, KK Spera, PA Barone, FC Feuerstein, GZ
Citation: Jj. Velier et al., Caspase-8 and caspase-3 are expressed by different populations of corticalneurons undergoing delayed cell death after focal stroke in the rat, J NEUROSC, 19(14), 1999, pp. 5932-5941
Molecular cloning and expression of the rat monocyte chemotactic protein-3gene: a possible role in stroke
Authors: Wang, XK Li, X Yaish-Ohad, S Sarau, HM Barone, FC Feuerstein, GZ
Citation: Xk. Wang et al., Molecular cloning and expression of the rat monocyte chemotactic protein-3gene: a possible role in stroke, MOL BRAIN R, 71(2), 1999, pp. 304-312
Risultati: 1-25 | 26-30